Lee S K, Anderson J P, Roberts E F. "Method for the Synthesis of Irbesartan Impurity 18" [P]. US Patent, US 11612751 B2, 2022-08-13.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 厄贝沙坦杂质18 in Pharmaceutical Formulations". Phytochemistry, 2011, 2423, (3), 4733-4745.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 厄贝沙坦杂质18 as an Impurity". Chemosphere, 2019, 2232, 6732-6750.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Irbesartan Impurity 18 Using HRMS and NMR". J. Nat. Prod., 2012, 608, 6789-6792.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 厄贝沙坦杂质18 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1426, 2361-2372.